| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 97,215 | 83,980 | 79,730 | 75,862 | | Cost of Revenue | 12,755 | 10,084 | 8,986 | 8,107 | | | Gross Profit | 84,460 | 73,896 | 70,744 | 67,755 | | | Operating Expenses | | Research Development | 31,551 | 28,646 | 20,959 | 179,751 | | Selling General and Administrative | 41,172 | 49,371 | 29,218 | 21,864 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,737 | (4,121) | 20,567 | (133,860) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 682 | 1,865 | 2,085 | 1,245 | | Earnings Before Interest And Taxes | 12,377 | (2,294) | 22,633 | (132,686) | | Interest Expense | 3,331 | 3,248 | 2,637 | 16 | | Income Before Tax | 9,046 | (5,542) | 19,996 | (132,702) | | Income Tax Expense | (2,891) | (3,200) | 6,799 | (51,557) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,937 | (2,342) | 13,197 | (81,145) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,937 | (2,342) | 13,197 | (81,145) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,937 | ($2,342) | $13,197 | ($81,145) |
|
0.01% Nasdaq 
0.22%
Income Statement
